Copenhagen / DK. (das) Danisco A/S has announced investments totalling 60 million EUR that will add more than 2’000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
The additional capacities will be located both in North America, where Danisco is transforming a former enzyme production unit from its Genencor Division into a cultures plant, and in Europe.
Profitable growth
With nine percent sales growth and 23 percent profitability growth compared to last year, Danisco Cultures Division is experiencing rapidly increasing market demand as more dairy manufacturers convert from traditional bulk starter cultures to the more reliable DVI solutions.
The steep demand growth curve is also fuelled by the continuous rise of the health + nutrition market, particularly for probiotic cultures in both dietary supplements and functional foods, the development of natural food protective solutions as well as the mainstream trend towards more natural and sustainable products as cultures benefit from consumer friendly labelling.
Furthermore, the acquisition in 2008 of the US company Agtech Products marked an important strategic step towards broadening Danisco Cultures´ market penetration by bringing cultures for animal nutrition and other non-food markets into the company portfolio.
Optimised industrial footprint
«We will accelerate our time-to-market to better serve our DVI customers using our production hubs in Europe and in the US», comments Doug Willrett, Executive Vice President, Danisco Cultures Division.
Danisco has already de-bottlenecked its capacity at several cultures production sites within the past year. The around 2’000 tonnes additional capacity is expected to progressively be commissioned over the next three years and will benefit from the latest process improvements developed by Danisco.
«Rochester´s transformation into a Cultures plant will enable us to save on time and capital expenditures and be ready in the US during the course of 2009», adds Willrett.
«This is a significant investment from Danisco, which demonstrates the Group´s long term commitment to be our customers´ First choice for their needs in state-of-the-art, affordable cultures», says Fabienne Saadane-Oaks, Danisco Bio Actives President.
OTHER TOPICS FROM THIS SECTION FOR YOU:
- SSP Group: announces Third Quarter Trading Update 2024
- LG Chem and ADM: Joint Ventures in Illinois are canceled
- Wendy’s: Company plans to expand into Europe
- Delivery Hero: may face significant fine due to antitrust violations
- Emmi Group: intends to acquire Mademoiselle Desserts
- AB Foods: announces strong H1-2024 performance
- DSM-Firmenich: Queen Maxima inaugurates new dual head office
- RBI: Announces Investments to Drive Growth in China
- Europastry S.A.: puts its IPO process on hold
- McCormick: Reports Second Quarter Performance
- Reborn Coffee: Closes Master License Agreement for UAE
- General Mills: Reports Fiscal 2024 Fourth-Quarter Results
- SunOpta expands plant for processing plant-based beverages
- Britannia: Operating profit grew 10 percent in FY-2023
- Tate + Lyle and CP Kelco to merge to leading global player
- Ülker Bisküvi: announces Q1-2024 financial results
- Europastry: intends to go public on the Spanish stock exchange
- Europastry S.A.: publishes 2023 Annual Report
- Swisslog: announces new Americas region headquarters
- Reborn Coffee: Expanding Omni-Channel Strategy